Christophe Meille

Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure

Timothy P. Hughes, Michael J. Mauro, Jörge E. Cortes et al. · New England Journal of Medicine · 2019 · 449 citations · Full text

Mathematical Modeling of Cancer Immunotherapy and Its Synergy with Radiotherapy

Raphaël Serre, Sébastien Benzekry, Laëtitia Padovani et al. · Cancer Research · 2016 · 181 citations · Full text

Immunology, Immunoediting, Pathology +17

Metabolic Profiling of Human Long-Term Liver Models and Hepatic Clearance Predictions from In Vitro Data Using Nonlinear Mixed-Effects Modeling

Nicole A. Kratochwil, Christophe Meille, Stephen Fowler et al. · The AAPS Journal · 2017 · 107 citations · Full text

Fatty Liver Disease, Physiologically-based Pharmacokinetic Modeling, Metabolic Syndrome +25

Physiologically based pharmacokinetic modeling of CYP3A4 induction by rifampicin in human: Influence of time between substrate and inducer administration

Guillaume Baneyx, Neil Parrott, Christophe Meille et al. · European Journal of Pharmaceutical Sciences · 2014 · 80 citations

Pharmacokinetic Modeling, Health Sciences, Physiology +10

Preclinical Optimization of MDM2 Antagonist Scheduling for Cancer Treatment by Using a Model-Based Approach

Brian Higgins, Kelli Glenn, Antje‐Christine Walz et al. · Clinical Cancer Research · 2014 · 60 citations · Full text